Biocryst Pharmaceuticals (BCRX) Share-based Compensation Growth (5y) (2015 - 2026)
Biocryst Pharmaceuticals (BCRX) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Biocryst Pharmaceuticals | 2.11 Bn | 1.87 Bn | 151.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.95% |
| Dec 31, 2025 | 32.22% |
| Sep 30, 2025 | 45.29% |
| Jun 30, 2025 | 45.38% |
| Mar 31, 2025 | 50.65% |
| Dec 31, 2024 | 42.06% |
| Sep 30, 2024 | 26.48% |
| Jun 30, 2024 | 45.79% |
| Mar 31, 2024 | 32.71% |
| Dec 31, 2023 | 47.97% |
| Sep 30, 2023 | 42.56% |
| Jun 30, 2023 | 43.86% |
| Mar 31, 2023 | 36.99% |
| Dec 31, 2022 | 45.87% |
| Sep 30, 2022 | 25.53% |
| Jun 30, 2022 | 33.51% |
| Mar 31, 2022 | 31.28% |
| Dec 31, 2021 | 33.44% |
| Sep 30, 2021 | 45.66% |
| Jun 30, 2021 | 32.83% |